Wednesday, July 27, 2016 8:25:42 PM
No one has made an offer, no one wants to finance it other than Cadwell. Not now, not in the last 3 years or 5 years or 10.
No experienced investor will unless they can have seats at the board, and push their weight around, control the manufacturing, the distribution, the pricing, budgeting, funding without making sure they have their hands in everything. ESPECIALLY in a penny company that even the state of Washington doesn't trust with their grant money and asked an outsider to monitor it. If you think someone will write a huge check for this company and will simply invest from an office across the world and let Jim keep this pace of "next quarter" you are wrong. If you had an employee or partner and they were running a division for you, you wouldn't give him a bonus for his division losing money would ya? You know damn well you wouldn't
ADMD isn't worth playing right now and hasn't been since it ran. momentum is going the wrong way and the impending RS coming without a AS lowering is a enormous red flag to anyone that is simply not trying to make a few bucks. Real players are busy playing earnings right now. Anyone else play F$ call options today? That's exactly what I am talking about. Long or short it doesn't matter this is a stock not a company. If after 3 years you only make $70K it's a hobby in the real world. No I am not talking about counting revenue from "financial engineering" I am talking about a bio medical device company talking about doing something for 5 years and still just talking about it.
GLTA
Recent RDGL News
- Form 8-K - Current report • Edgar (US Regulatory) • 12/27/2023 09:40:48 PM
- Form QUALIF - Notice of Qualification [Regulation A] • Edgar (US Regulatory) • 12/07/2023 05:15:10 AM
- Form 1-A POS - • Edgar (US Regulatory) • 11/27/2023 10:29:12 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/06/2023 04:28:46 PM
- Form 1-A POS - • Edgar (US Regulatory) • 11/03/2023 09:03:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/19/2023 04:18:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/11/2023 10:33:58 AM
- Form 1-A POS - • Edgar (US Regulatory) • 10/10/2023 04:05:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/04/2023 07:22:21 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM